PDF herunterladen
Thromb Haemost 2017; 117(05): 837-850
DOI: 10.1160/TH16-11-0825
Coagulation and Fibrinolysis
Schattauer GmbH

Are cardiovascular risk factors also associated with the incidence of atrial fibrillation?

A systematic review and field synopsis of 23 factors in 32 population-based cohorts of 20 million participants
Victoria Allan
1   Farr Institute of Health Informatics Research, Institute of Health Informatics, University College London, London, UK
,
Shohreh Honarbakhsh
2   The Barts Heart Centre, St Bartholomew’s Hospital, Barts Health NHS Trust & Queen Mary, University of London, London, UK
,
Juan-Pablo Casas
1   Farr Institute of Health Informatics Research, Institute of Health Informatics, University College London, London, UK
,
Joshua Wallace
1   Farr Institute of Health Informatics Research, Institute of Health Informatics, University College London, London, UK
,
Ross Hunter
2   The Barts Heart Centre, St Bartholomew’s Hospital, Barts Health NHS Trust & Queen Mary, University of London, London, UK
,
Richard Schilling
2   The Barts Heart Centre, St Bartholomew’s Hospital, Barts Health NHS Trust & Queen Mary, University of London, London, UK
,
Pablo Perel
3   Centre for Global Non Communicable Diseases, London School of Hygiene & Tropical Medicine, London, UK
,
Katherine Morley
4   Institute of Psychiatry, Psychology & Neuroscience, Kings College London, London, UK
,
Amitava Banerjee
1   Farr Institute of Health Informatics Research, Institute of Health Informatics, University College London, London, UK
,
Harry Hemingway
1   Farr Institute of Health Informatics Research, Institute of Health Informatics, University College London, London, UK
› Institutsangaben
Financial support: This work was supported by the 10 funders of the Farr Institute of Health Informatics Research: The Medical Research Council (MRC) [K006584/1] in partnership with Arthritis Research UK; the British Heart Foundation; Cancer Research UK; the Economic and Social Research Council; the Engineering and Physical Sciences Research Council; the National Institute for Health Research; the National Institute for Social Care and Health Research (Welsh Assembly Government); the Chief Scientist Office (Scottish Government Health Directorates); and the Wellcome Trust, as well as the MRC PROGnosis RESearch Strategy Partnership [G0902393]. The study funders had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.
Weitere Informationen

Publikationsverlauf

Received: 02. November 2016

Accepted after major revision: 02. Februar 2017

Publikationsdatum:
28. November 2017 (online)

  Lizenzen und Reprints

Summary

Established primary prevention strategies of cardiovascular diseases are based on understanding of risk factors, but whether the same risk factors are associated with atrial fibrillation (AF) remains unclear. We conducted a systematic review and field synopsis of the associations of 23 cardiovascular risk factors and incident AF, which included 84 reports based on 28 consented and four electronic health record cohorts of 20,420,175 participants and 576,602 AF events. We identified 3-19 reports per risk factor and heterogeneity in AF definition, quality of reporting, and adjustment. We extracted relative risks (RR) and 95 % confidence intervals [CI] and visualised the number of reports with inverse (RR [CI]<1.00), or direct (RR [CI]>1.00) associations. For hypertension (13/17 reports) and obesity (19/19 reports), there were direct associations with incident AF, as there are for coronary heart disease (CHD). There were inverse associations for non-White ethnicity (5/5 reports, with RR from 0.35 to 0.84 [0.82–0.85]), total cholesterol (4/13 reports from 0.76 [0.59–0.98] to 0.94 [0.90–0.97]; 8/13 reports with non-significant inverse associations), and diastolic blood pressure (2/11 reports from 0.87 [0.78–0.96] to 0.92 [0.85–0.99]; 5/11 reports with non-significant inverse associations), and direct associations for taller height (7/10 reports from 1.03 [1.02–1.05] to 1.92 [1.38–2.67]), which are in the opposite direction of known associations with CHD. A systematic evaluation of the available evidence suggests similarities as well as important differences in the risk factors for incidence of AF as compared with other cardiovascular diseases, which has implications for the primary prevention strategies for atrial fibrillation.

Keywords

Atrial fibrillation - risk factors - primary prevention - clinical guidelines - cardiovascular disease

 

  • References

  • 1 Chugh SS. et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 2014; 129: 837-847.
    CrossrefPubMedSuche in Google Scholar
  • 2 Marini C. et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke 2005; 36: 1115-1119.
    CrossrefPubMedSuche in Google Scholar
  • 3 Benjamin EJ. et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98: 946-952.
    CrossrefPubMedSuche in Google Scholar
  • 4 Blomstrom Lundqvist C. et al. What are the costs of atrial fibrillation?. Europace 2011; 13 (Suppl. 02) ii9-12.
    PubMedSuche in Google Scholar
  • 5 Miyasaka Y. et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006; 114: 119-125.
    CrossrefPubMedSuche in Google Scholar
  • 6 Krijthe BP. et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J 2013; 34: 2746-2751.
    CrossrefPubMedSuche in Google Scholar
  • 7 Savelieva I. et al. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention. Europace 2011; 13: 308-328.
    CrossrefPubMedSuche in Google Scholar
  • 8 Moran PS. et al. Effectiveness of systematic screening for the detection of atrial fibrillation. Cochrane Database System Rev 2013; 04: Cd009586.
    PubMedSuche in Google Scholar
  • 9 January CT. et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 2014; 130: 2071-2104.
    CrossrefPubMedSuche in Google Scholar
  • 10 Kirchhof P. et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC)Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESCEndorsed by the European Stroke Organisation (ESO). Eur Heart J. 2016 Epub ahead of print.
    PubMedSuche in Google Scholar
  • 11 Jones C. et al. The management of atrial fibrillation: summary of updated NICE guidance. Br Med J 2014; 348: g3655.
    CrossrefPubMedSuche in Google Scholar
  • 12 Perk J. et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012; 33: 1635-1701.
    CrossrefPubMedSuche in Google Scholar
  • 13 Goldstein LB. et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42: 517-584.
    CrossrefPubMedSuche in Google Scholar
  • 14 Samokhvalov AV. et al. Alcohol consumption as a risk factor for atrial fibrillation: a systematic review and meta-analysis. Eur J Cardiovasc Prevent Rehabil 2010; 17: 706-712.
    CrossrefPubMedSuche in Google Scholar
  • 15 Kodama S. et al. Alcohol consumption and risk of atrial fibrillation: a meta-analysis. J Am Coll Cardiol 2011; 57: 427-436.
    CrossrefPubMedSuche in Google Scholar
  • 16 Larsson SC. et al. Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis. J Am Coll Cardiol 2014; 64: 281-289.
    CrossrefPubMedSuche in Google Scholar
  • 17 Wu N. et al. Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: a meta-analysis. Internat J Cardiol 2013; 169: 62-72.
    CrossrefPubMedSuche in Google Scholar
  • 18 Huxley RR. et al. Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation. Am J Cardiol 2011; 108: 56-62.
    CrossrefPubMedSuche in Google Scholar
  • 19 Wanahita N. et al. Atrial fibrillation and obesity--results of a meta-analysis. Am Heart J 2008; 155: 310-315.
    CrossrefPubMedSuche in Google Scholar
  • 20 Ofman P. et al. Regular physical activity and risk of atrial fibrillation: a systematic review and meta-analysis. Circulation Arrhythm Electrophysiol 2013; 06: 252-256.
    CrossrefPubMedSuche in Google Scholar
  • 21 Kwok CS. et al. Physical activity and incidence of atrial fibrillation: a systematic review and meta-analysis. Internat J Cardiol 2014; 177: 467-476.
    CrossrefPubMedSuche in Google Scholar
  • 22 Zimmerman D. et al. Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis. Nephrol Dial Transplant 2012; 27: 3816-3822.
    CrossrefPubMedSuche in Google Scholar
  • 23 Ioannidis JP. et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Internat J Epidemiol 2008; 37: 120-132.
    CrossrefPubMedSuche in Google Scholar
  • 24 Kuper H. et al. Evaluating the causal relevance of diverse risk markers: horizontal systematic review. Br Med J 2009; 339: b4265.
    CrossrefPubMedSuche in Google Scholar
  • 25 Moher D. et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Br Med J 2009; 339: b2535.
    CrossrefPubMedSuche in Google Scholar
  • 26 Hemingway H. et al. Evaluating the quality of research into a single prognostic biomarker: a systematic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery disease. PLoS Med 2010; 07: e1000286.
    CrossrefPubMedSuche in Google Scholar
  • 27 Azarbal F. et al. Obesity, physical activity, and their interaction in incident atrial fibrillation in postmenopausal women. J Am Heart Assoc 2014; 03 pii e001127
    CrossrefPubMedSuche in Google Scholar
  • 28 Perez MV. et al. Risk factors for atrial fibrillation and their population burden in postmenopausal women: the Women’s Health Initiative Observational Study. Heart 2013; 99: 1173-1178.
    CrossrefPubMedSuche in Google Scholar
  • 29 Drca N. et al. Atrial fibrillation is associated with different levels of physical activity levels at different ages in men. Heart 2014; 100: 1037-1042.
    CrossrefPubMedSuche in Google Scholar
  • 30 Watanabe H. et al. Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study. Am Heart J 2009; 158: 629-636.
    CrossrefPubMedSuche in Google Scholar
  • 31 Watanabe H. et al. Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation 2008; 117: 1255-1260.
    CrossrefPubMedSuche in Google Scholar
  • 32 Watanabe H. et al. Association between lipid profile and risk of atrial fibrillation. Circulation J 2011; 75: 2767-2774.
    CrossrefPubMedSuche in Google Scholar
  • 33 Drca N. et al. Physical activity is associated with a reduced risk of atrial fibrillation in middle-aged and elderly women. Heart 2015; 101: 1627-1630.
    CrossrefPubMedSuche in Google Scholar
  • 34 Frost L. et al. Body fat, body fat distribution, lean body mass and atrial fibrillation and flutter. A Danish cohort study. Obesity 2014; 22: 1546-1552.
    CrossrefPubMedSuche in Google Scholar
  • 35 Frost L. et al. Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Med 2005; 118: 489-495.
    CrossrefPubMedSuche in Google Scholar
  • 36 Frost L. et al. Work related physical activity and risk of a hospital discharge diagnosis of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Occupat Environment Med 2005; 62: 49-53.
    PubMedSuche in Google Scholar
  • 37 Fedorowski A. et al. Orthostatic hypotension and long-term incidence of atrial fibrillation: the Malmo Preventive Project. J Intern Med 2010; 268: 383-389.
    CrossrefPubMedSuche in Google Scholar
  • 38 Misialek JR. et al. Socioeconomic status and the incidence of atrial fibrillation in whites and blacks: the Atherosclerosis Risk in Communities (ARIC) study. J Am Heart Assoc 2014; 03 pii e001159
    CrossrefPubMedSuche in Google Scholar
  • 39 Huxley RR. et al. Physical activity, obesity, weight change, and risk of atrial fibrillation: the Atherosclerosis Risk in Communities study. Circulation Arrhyth Electrophysiol 2014; 07: 620-625.
    PubMedSuche in Google Scholar
  • 40 Huxley RR. et al. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2011; 123: 1501-1508.
    CrossrefPubMedSuche in Google Scholar
  • 41 Lopez FL. et al. Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: the atherosclerosis risk in communities study. Circulation Arrhyth Electrophysiol 2012; 05: 155-162.
    PubMedSuche in Google Scholar
  • 42 Alonso A. et al. Hemostatic markers are associated with the risk and prognosis of atrial fibrillation: the ARIC study. Internat J Cardiol 2012; 155: 217-222.
    CrossrefPubMedSuche in Google Scholar
  • 43 Alonso A. et al. Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 2009; 158: 111-117.
    CrossrefPubMedSuche in Google Scholar
  • 44 Marcus GM. et al. European ancestry as a risk factor for atrial fibrillation in African Americans. Circulation 2010; 122: 2009-2015.
    CrossrefPubMedSuche in Google Scholar
  • 45 Alonso A. et al. Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2011; 123: 2946-2953.
    CrossrefPubMedSuche in Google Scholar
  • 46 Chamberlain AM. et al. A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study). Am J Cardiol 2011; 107: 85-91.
    CrossrefPubMedSuche in Google Scholar
  • 47 Alonso A. et al. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc 2013; 02: e000102.
    PubMedSuche in Google Scholar
  • 48 Jensen PN. et al. Racial differences in the incidence of and risk factors for atrial fibrillation in older adults: the cardiovascular health study. J Am Geriatr Soc 2013; 61: 276-280.
    CrossrefPubMedSuche in Google Scholar
  • 49 Mozaffarian D. et al. Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study. Circulation 2008; 118: 800-807.
    CrossrefPubMedSuche in Google Scholar
  • 50 Aviles RJ. et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003; 108: 3006-3010.
    CrossrefPubMedSuche in Google Scholar
  • 51 Cappola AR. et al. Thyroid function in the euthyroid range and adverse outcomes in older adults. J Clin Endocrinol Metabol 2015; 100: 1088-1096.
    CrossrefPubMedSuche in Google Scholar
  • 52 Deo R. et al. Impaired kidney function and atrial fibrillation in elderly subjects. J Cardiac Fail 2010; 16: 55-60.
    CrossrefPubMedSuche in Google Scholar
  • 53 Psaty BM. et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997; 96: 2455-2461.
    CrossrefPubMedSuche in Google Scholar
  • 54 Smith JG. et al. Atrial fibrillation in the Malmo Diet and Cancer study: a study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol 2010; 25: 95-102.
    CrossrefPubMedSuche in Google Scholar
  • 55 Smith JG. et al. Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation. J Am Coll Cardiol 2010; 56: 1712-1719.
    CrossrefPubMedSuche in Google Scholar
  • 56 Rosengren A. et al. Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men. Eur Heart J 2009; 30: 1113-1120.
    CrossrefPubMedSuche in Google Scholar
  • 57 Xu D. et al. Anemia and reduced kidney function as risk factors for new onset of atrial fibrillation (from the Ibaraki prefectural health study). Am J Cardiol 2015; 115: 328-333.
    CrossrefPubMedSuche in Google Scholar
  • 58 Schoen T. et al. Type 2 diabetes mellitus and risk of incident atrial fibrillation in women. J Am Coll Cardiol 2012; 60: 1421-1428.
    CrossrefPubMedSuche in Google Scholar
  • 59 Everett BM. et al. Physical activity and the risk of incident atrial fibrillation in women. Circulation Cardiovasc Qual Outcom 2011; 04: 321-327.
    PubMedSuche in Google Scholar
  • 60 Tedrow UB. et al. The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women’s health study). J Am Coll Cardiol 2010; 55: 2319-2327.
    CrossrefPubMedSuche in Google Scholar
  • 61 Mora S. et al. Paradoxical association of lipoprotein measures with incident atrial fibrillation. Circulation Arrhythm Electrophysiol 2014; 07: 612-619.
    CrossrefPubMedSuche in Google Scholar
  • 62 Sandhu RK. et al. Relation of renal function to risk for incident atrial fibrillation in women. Am J Cardiol 2012; 109: 538-542.
    CrossrefPubMedSuche in Google Scholar
  • 63 Conen D. et al. A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women. Eur Heart J 2010; 31: 1730-1736.
    CrossrefPubMedSuche in Google Scholar
  • 64 Conen D. et al. Alcohol consumption and risk of incident atrial fibrillation in women. J Am Med Assoc 2008; 300: 2489-2496.
    CrossrefPubMedSuche in Google Scholar
  • 65 Conen D. et al. Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation 2009; 119: 2146-2152.
    CrossrefPubMedSuche in Google Scholar
  • 66 Thelle DS. et al. Resting heart rate and physical activity as risk factors for lone atrial fibrillation: a prospective study of 309,540 men and women. Heart 2013; 99: 1755-1760.
    CrossrefPubMedSuche in Google Scholar
  • 67 Nyrnes A. et al. Palpitations are predictive of future atrial fibrillation. An 11-year follow-up of 22,815 men and women: the Tromso Study. Eur J Prevent Cardiol 2013; 20: 729-736.
    PubMedSuche in Google Scholar
  • 68 Nyrnes A. et al. Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromso study. Gender Med 2012; 09: 536-547. e2
    CrossrefPubMedSuche in Google Scholar
  • 69 Mitchell GF. et al. Pulse pressure and risk of new-onset atrial fibrillation. J Am Med Assoc 2007; 297: 709-715.
    CrossrefPubMedSuche in Google Scholar
  • 70 Schnabel RB. et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet 2009; 373: 739-745.
    CrossrefPubMedSuche in Google Scholar
  • 71 Alonso A. et al. Blood lipids and the incidence of atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis and the Framingham Heart Study. J Am Heart Assoc 2014; 03: e001211.
    CrossrefPubMedSuche in Google Scholar
  • 72 Sawin CT. et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994; 331: 1249-1252.
    CrossrefPubMedSuche in Google Scholar
  • 73 Schnabel RB. et al. Relation of multiple inflammatory biomarkers to incident atrial fibrillation. Am J Cardiol 2009; 104: 92-96.
    CrossrefPubMedSuche in Google Scholar
  • 74 Adamsson Eryd S. et al. Inflammation-sensitive proteins and risk of atrial fibrillation: a population-based cohort study. Eur J Epidemiol 2011; 26: 449-455.
    CrossrefPubMedSuche in Google Scholar
  • 75 Sinner MF. et al. B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies. Europace 2014; 16: 1426-1433.
    CrossrefPubMedSuche in Google Scholar
  • 76 Schnabel RB, Aspelund T, Li G. et al. Validation of an atrial fibrillation risk algorithm in whites and African Americans. Arch Intern Med 2010; 170: 1909-1917.
    PubMedSuche in Google Scholar
  • 77 Chaker L. et al. Normal Thyroid Function and the Risk of Atrial Fibrillation: the Rotterdam Study. J Clin Endocrinol Metabol 2015; 100: 3718-3724.
    CrossrefPubMedSuche in Google Scholar
  • 78 Heeringa J. et al. Cigarette smoking and risk of atrial fibrillation: the Rotterdam Study. Am Heart J 2008; 156: 1163-1169.
    CrossrefPubMedSuche in Google Scholar
  • 79 Friberg J. et al. Rising rates of hospital admissions for atrial fibrillation. Epidemiology 2003; 14: 666-672.
    CrossrefPubMedSuche in Google Scholar
  • 80 Mukamal KJ. et al. Fibrinogen and albumin levels and risk of atrial fibrillation in men and women (the Copenhagen City Heart Study). Am J Cardiol 2006; 98: 75-81.
    CrossrefPubMedSuche in Google Scholar
  • 81 Aronis KN. et al. Associations of obesity and body fat distribution with incident atrial fibrillation in the biracial health aging and body composition cohort of older adults. Am Heart J 2015; 170: 498-505. e2
    CrossrefPubMedSuche in Google Scholar
  • 82 Collet TH. et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med 2012; 172: 799-809.
    PubMedSuche in Google Scholar
  • 83 Knuiman M. et al. A cohort study examination of established and emerging risk factors for atrial fibrillation: the Busselton Health Study. Eur J Epidemiol 2014; 29: 181-190.
    CrossrefPubMedSuche in Google Scholar
  • 84 Roetker NS. et al. Relation of systolic, diastolic, and pulse pressures and aortic distensibility with atrial fibrillation (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol 2014; 114: 587-592.
    CrossrefPubMedSuche in Google Scholar
  • 85 Rodriguez CJ. et al. Atrial fibrillation incidence and risk factors in relation to race-ethnicity and the population attributable fraction of atrial fibrillation risk factors: the Multi-Ethnic Study of Atherosclerosis. Ann Epidemiol 2015; 25: 71-76 6.e1
    CrossrefPubMedSuche in Google Scholar
  • 86 Bapat A. et al. Relation of Physical Activity and Incident Atrial Fibrillation (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol 2015; 116: 883-888.
    CrossrefPubMedSuche in Google Scholar
  • 87 O’Neal WT. et al. Sustained pre-hypertensive blood pressure and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis. J Am Soc Hyperten 2015; 09: 191-196.
    PubMedSuche in Google Scholar
  • 88 Sano F. et al. Heavy alcohol consumption and risk of atrial fibrillation. The Circulatory Risk in Communities Study (CIRCS). Circulation J 2014; 78: 955-961.
    CrossrefPubMedSuche in Google Scholar
  • 89 Nystrom PK. et al. Obesity, metabolic syndrome and risk of atrial fibrillation: a Swedish, prospective cohort study. PloS one 2015; 10: e0127111.
    CrossrefPubMedSuche in Google Scholar
  • 90 Grundvold I. et al. Importance of physical fitness on predictive effect of body mass index and weight gain on incident atrial fibrillation in healthy middle-age men. Am J Cardiol 2012; 110: 425-432.
    CrossrefPubMedSuche in Google Scholar
  • 91 Kokubo Y. et al. Interaction of Blood Pressure and Body Mass Index With Risk of Incident Atrial Fibrillation in a Japanese Urban Cohort: The Suita Study. Am J Hyperten 2015; 28: 1355-1361.
    CrossrefPubMedSuche in Google Scholar
  • 92 Dewland TA. et al. Incident atrial fibrillation among Asians, Hispanics, blacks, and whites. Circulation 2013; 128: 2470-2477.
    CrossrefPubMedSuche in Google Scholar
  • 93 Lindhardsen J. et al. Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study. Br Med J 2012; 344: e1257.
    CrossrefPubMedSuche in Google Scholar
  • 94 Ahlehoff O. et al. Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study. Eur Heart J 2012; 33: 2054-2064.
    CrossrefPubMedSuche in Google Scholar
  • 95 Pallisgaard JL. et al. Risk of atrial fibrillation in diabetes mellitus: A nationwide cohort study. Eur J Prevent Cardiol 2016; 23: 621-627.
    PubMedSuche in Google Scholar
  • 96 Selmer C. et al. The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study. Br Med J 2012; 345: e7895.
    CrossrefPubMedSuche in Google Scholar
  • 97 Emilsson L. et al. Increased risk of atrial fibrillation in patients with coeliac disease: a nationwide cohort study. Eur Heart J 2011; 32: 2430-2437.
    CrossrefPubMedSuche in Google Scholar
  • 98 Chiang CH. et al. Herpes simplex virus infection and risk of atrial fibrillation: a nationwide study. Internat J Cardiol 2013; 164: 201-204.
    CrossrefPubMedSuche in Google Scholar
  • 99 Gorenek B. et al. European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). Europace. 2016 Epub ahead of print.
    PubMedSuche in Google Scholar
  • 100 Schneider MP. et al. Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis. J Am Coll Cardiol 2010; 55: 2299-2307.
    CrossrefPubMedSuche in Google Scholar
  • 101 Emdin CA. et al. Effect of antihypertensive agents on risk of atrial fibrillation: a meta-analysis of large-scale randomized trials. Europace 2015; 17: 701-710.
    CrossrefPubMedSuche in Google Scholar
  • 102 Rahimi K. et al. Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials. Br Med J 2011; 342: d1250.
    CrossrefPubMedSuche in Google Scholar
  • 103 Rapsomaniki E. et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people. Lancet 2014; 383: 1899-1911.
    CrossrefPubMedSuche in Google Scholar
  • 104 Lokaj P. et al. Pulse Pressure in Clinical Practice. Eur J Cardiovasc Med 2012; 02: Abstract.
    PubMedSuche in Google Scholar
  • 105 National Institute for Health and Care Excellence (NICE). Hypertension in adults: diagnosis and management. Available at: https://www.nice.org.uk/guidance/cg127 Accessed March 1, 2016
    PubMed
  • 106 Danesh J. et al. The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol 2007; 22: 839-869.
    CrossrefPubMedSuche in Google Scholar
  • 107 Denaxas SC. et al. Data resource profile: cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER). Internat J Epidemiol 2012; 41: 1625-1638.
    CrossrefPubMedSuche in Google Scholar
  • 108 Montori VM. et al. Optimal search strategies for retrieving systematic reviews from Medline: analytical survey. Br Med J 2005; 330: 68.
    CrossrefPubMedSuche in Google Scholar
  • 109 Kwon Y. et al. An assessment of the efficacy of searching in biomedical databases beyond MEDLINE in identifying studies for a systematic review on ward closures as an infection control intervention to control outbreaks. System Rev 2014; 03: 135.
    PubMedSuche in Google Scholar
  • 110 Stevinson C, Lawlor DA. Searching multiple databases for systematic reviews: added value or diminishing returns?. Complement Therap Med 2004; 12: 228-232.
    PubMedSuche in Google Scholar
  • 111 Lemeshow AR. et al. Searching one or two databases was insufficient for meta-analysis of observational studies. J Clin Epidemiol 2005; 58: 867-873.
    CrossrefPubMedSuche in Google Scholar
  • 112 Horton R. The less acceptable face of bias. Lancet 2000; 356: 959-960.
    CrossrefPubMedSuche in Google Scholar
  • 113 Nelson CP, Hamby SE, Saleheen D. et al. Genetically determined height and coronary artery disease. N Engl J Med 2015; 372: 1608-1618.
    CrossrefPubMedSuche in Google Scholar